Inspira Technologies (IINN) announced that the Japan Patent Office has granted Patent No. 7777598. This patent covers the Company’s novel Convertible Dual Lumen Cannula device and method of use, securing exclusive rights in one of the world’s most advanced medical device markets. The patent grants Inspira exclusive commercial rights in the patented Dual Lumen Cannula technology in Japan through 2041.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IINN:
- Inspira Technologies Expands Lab Capabilities for Growth
- Inspira Technologies announces expansion of core blood laboratory capabilities
- Inspira Technologies Announces Annual and Extraordinary General Meeting for December 2025
- Inspira Technologies Completes Clinical Study for HYLA Blood Sensor
- Inspira Technologies completes clinical study for HYLA blood sensor